These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
3. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins. Khan F; Brady S; Kuttikat A Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115 [TBL] [Abstract][Full Text] [Related]
4. Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report. Upreti S; Fayyaz B; Bongu RP J Community Hosp Intern Med Perspect; 2019; 9(1):33-35. PubMed ID: 30788073 [TBL] [Abstract][Full Text] [Related]
5. Statin-induced myopathy: a case report. De Cock E; Hannon H; Moerman V; Schurgers M Eur Heart J Case Rep; 2018 Dec; 2(4):yty130. PubMed ID: 31020206 [TBL] [Abstract][Full Text] [Related]
8. A Case of Statin-Associated Immune-Mediated Necrotizing Myopathy, Successfully Treated With Intravenous Immunoglobulin. Paul M; Paul P; Dey D; Moazzem SW; Shamrin F Cureus; 2021 Jun; 13(6):e16001. PubMed ID: 34336492 [TBL] [Abstract][Full Text] [Related]
10. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness. Fink NS; Abubshait L; Deshisky A Cureus; 2024 May; 16(5):e61094. PubMed ID: 38919212 [TBL] [Abstract][Full Text] [Related]
11. Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders. Woolley M; Stebbings S; Highton J Intern Med J; 2018 Jan; 48(1):32-36. PubMed ID: 28782163 [TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report. Luong MT; Danahy P; Ho GY Cureus; 2023 Jul; 15(7):e42266. PubMed ID: 37605694 [TBL] [Abstract][Full Text] [Related]
14. Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy. Ghazal F; Zur M; Silver A Cureus; 2023 Jan; 15(1):e34121. PubMed ID: 36843759 [TBL] [Abstract][Full Text] [Related]
15. Unveiling the Rare Complication: Statin-Induced Immune-Mediated Necrotizing Myopathy. Chowdhury FH; Mahneva O; Maharaj M; Marciales W Am J Case Rep; 2023 Dec; 24():e941387. PubMed ID: 38087774 [TBL] [Abstract][Full Text] [Related]
16. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830 [TBL] [Abstract][Full Text] [Related]
17. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428 [TBL] [Abstract][Full Text] [Related]